![](https://medcitynews.com/wp-content/uploads/sites/7/2020/02/GettyImages-1199224698-e1581610655874.jpg)
CanSino beats Moderna again, this time to peer-reviewed, published Covid-19 vaccine data
The Tianjin, China-based company, which was the first to move a vaccine into Phase II development, also became the first to published peer-reviewed data, from its Phase I study. Moderna released preliminary data this week, but it was seen as too early for interpreting its vaccine's efficacy.